Akari Therapeutics (AKTX) announced the appointment of Abizer Gaslightwala as President and Chief Executive Officer, CEO, effective April 21, 2025. He joins Akari having most recently served as the Senior Vice President and Franchise Head for US Oncology at Jazz Pharmaceuticals (JAZZ)
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKTX:
Questions or Comments about the article? Write to editor@tipranks.com